Cutting-Edge Various Diseases Therapeutics Markets Research Reports Developed by DelveInsight Recently Published at MarketPublishers.com

26 Jul 2016 • by Natalie Aster

LONDON - TD The Market Publishers, Ltd. is excited to inform that new unrivalled research reports covering various diseases therapeutics markets developed by DelveInsight have been recently published at MarketPublishers.com.

Graft vs. Host Disease - Competitive Landscape, Technology and Pipeline Analysis, 2016. The key objective of this new unbiased research report is to analyse the global market for graft versus host disease drugs, with a main focus on the pipeline drugs. The report also includes valuable drug profiles, containing product description as well as data on MOA, licensors and collaborators, development partners and chemical information. Companies involved into the therapeutics development activity are reviewed in the report along with an overview of the key market growth hinders and drivers…

Microbiome-Competitive Landscape, Technology and Pipeline Analysis, 2016. The new unparalleled report provides an in-depth review of the microbiome pipeline drugs and a holistic analysis of the global microbiome therapeutics market. The comprehensive report includes vital information related to the microbiome therapeutics development, gives data on the major market participants and their therapeutics achievements. Moreover, this report highlights the most recent microbiome technologies and innovations. Besides, the report explores emerging trends and gives a comparative analysis of pipeline products with detailed clinical descriptions…

Janus Kinase Inhibitor (JAK) Inhibitors- Competitive Landscape, Technology and Pipeline Analysis, 2016. This research publication delves deep into the global market for janus kinase (JAK) inhibitors market, covering the current market scenario, looking at the historical background and offering future forecasts for the market development. A comprehensive overview of the pipeline drugs is at hand in this all-encompassing study along with trustworthy information on more than 20 companies involved in the therapeutic development. A comparative analysis of JAK inhibitors at various development stages is also provided here…

Mammalian Target of Rapamycin (Mtor) Inhibitors, Pipeline Insights, 2016. The mammalian target of rapamycin (mTOR) inhibitors market is carefully investigated in this new research report. The study also provides a comprehensive insight into the pipeline drugs development, analyses over 20 existing drugs and profiles more than 18 companies active in the marketplace. Moreover, the emerging players with potentially strong product portfolios and licensing opportunities are identified in the report. The market competitive scenario is thoroughly covered, key competitive pressures are discussed and the major factors shaping the market are examined in the report…

More new comprehensive research reports developed by the publisher can be easily found at DelveInsight page.

CONTACTS

The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected]
MarketPublishers.com